Each softgel capsule contains extracts derived from: Triphala (Terminalia chebula, Terminalia belerica, Emblica officinalis) 75 mg, Phyllanthus niruri 20 mg, Eclipta alba 15 mg, Fumaria parviflora 10 mg, Piper longum 8.33 mg, Berberis aristata 6.66 mg, Picrorrhiza kurroa 6.25 mg, Boerhaavia diffusa 5.88 mg, Andrographis paniculata 5 mg, Zingiber officinale 5 mg, Tinospora cordifolia 4.16 mg, Plumbago zeylanica 3.33 mg.
It is available as soft gel capsule. It contains herbs with remarkable properties which stimulates detoxification, liver cell proliferation, antiviral activity (Hepatitis B, Hepatitis C, etc), anti-hepatotoxicity (antioxidants and others), stimulation of liver regeneration, choleretic and cholegogue activity.
Liverpro restores depleted glutathione (GSH) levels, thereby enhancing detoxification and antioxidation, and helping maintain a normal oxidation-reduction balance.
Hepatitis (alcoholic, drug, environmental toxins etc. induced): Liverpro reduces inflammation of hepatocytes and improves clinical signs and symptoms. Liverpro restores normal enzymatic levels and improves liver metabolic function.
Adjuvant to hepatotoxic drugs (Anti-tubercular drugs, Statins, NSAIDS, Chemotherapeutic agents and Anti-retrovirals): Liverpro enhances detoxification and corrects oxidative stress. Liverpro modulates inflammatory and immune response and protects liver from further damage. Liverpro helps repair damage and rejuvenate hepatic cells.
Prophylactic therapy: Environmental toxins, chemicals, food habits, drugs, contaminated water, processed food results in accumulation of toxins in liver cells which leads to inflammation of hepatocytes and further progress to liver disorder. Liverpro detoxifies liver cells and rejuvenates liver cells. It protets liver from inflammation and oxidative stress. Liverpro enhances liver cell immunity and forms shield against damage from harmful toxins.
Non-alcoholic fatty liver disease (NAFLD): Fatty liver disease is abnormal amount of fats accumulation in the liver leading to inflammation and scarring of the liver. The liver metabolic functions are hampered leading to further irreversible damage of liver cells. Liverpro reduces inflammation and oxidative stress and prevents progression of NAFLD to NASH.
Adults: 1-2 SGCs for minimum 1-2 months or as directed by the physician.
To be taken under prescription and supervision of physician.
Please avoid taking medicine if found allergic to particular ingredient mentioned in the composition.
For adults use only.
To be taken under medical supervision.
Liverpro is well tolerated by all patients and no side effects have been observed till date.
No absolute interaction with food and drug noted.
Combination with any other drug taken together under the guidance and supervision of a health care provider.
Store in a cool, dry place. Protect from direct sunlight.
Best before 36 months from date of manufacturing.
A05BA - Liver therapy ; Used in liver therapy.
Liverpro softgel cap